A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for advanced non-small-cell lung cancer - Castellano, D.; Lianes, P.; Paz-Ares, L.; Hidalgo, M.; Guerra, J. A.; Gómez-Martín, C.; Gómez, H.; Calzas, J.; Cortés-Funes, H. (Springer, 1998)
http://dx.doi.org/10.1023/A:1008276507236
Keywords: WW-YZ